Consensus Northwest Biotherapeutics, Inc. Börse Stuttgart
Stocks
NBYB
US66737P6007
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1500 EUR | -6.25% |
|
-6.25% | -27.18% |
Evolution of the Average Target: Northwest Biotherapeutics, Inc.
Evolution of the Target Price: Northwest Biotherapeutics, Inc.
Changes in Analyst Recommendations: Northwest Biotherapeutics, Inc.
1b3167a9.h3aTh_r1d_UME-UtLnne3XM3AnzApZFFvzSG_cmVrjg.zTzJ9rycB4doYJFmayiY6EVZUwqG1cZy0HXKiPzjw3LoO8bdr9gTxmdmrA~3bee7c67d2eceeb76c5cffaa067c0dd5
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +24.29% | |||||
| +16.73% | |||||
| +79.89% | |||||
| +35.55% | |||||
| +26.41% | |||||
| +22.58% | |||||
| -15.4% | |||||
| +8.66% | |||||
| -9.11% | |||||
| Average | +21.07% | |||||
| Weighted average by Cap. | +23.56% |
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1719USD
Average target price
1.000USD
Spread / Average Target
+481.73%
High Price Target
1.000USD
Spread / Highest target
+481.73%
Low Price Target
1.000USD
Spread / Lowest Target
+481.73%
Analyst Consensus Detail
Consensus revision (last 18 months)
SellBuy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1719USD
Average target price
1.000USD
Spread / Average Target
+481.73%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NWBO Stock
- NBYB Stock
- Consensus Northwest Biotherapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
